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Case Report
A 47-year-old man with known metastatic small cell lung
cancer presented with 1 week of right arm swelling, facial
ﬂushing, shortness of breath, right hand weakness, and
intermittent blurry vision. Physical examination revealed
right upper extremity edema and facial plethora. Computed
tomography (CT) of the chest conﬁrmed enlargement of a
right upper lobemass causing near-complete occlusion of the
right brachiocephalic vein and superior vena cava (SVC)
(►Fig. 1), consistent with SVC syndrome (SVCS). After exten-
sive discussion regarding the risks and beneﬁts of the proce-
dure, the patient elected to proceed with endovascular
reconstruction of the central veins.
Bilateral basilic vein access was obtained, and digital
upper extremity venography conﬁrmed near-complete oc-
clusion of the SVC (►Fig. 2). The occlusion was traversed
using a 0.035-inch wire and a 5F catheter, and intraluminal
crossing was conﬁrmed with contrast injection. Through-
and-through access was obtained via the right common
femoral vein, and the SVC and brachiocephalic veins were
dilated using 8- and 10-mm balloons (►Fig. 3). Venogram
immediately following the 10-mm angioplasty demon-
strated contrast extravasation into the mediastinum and
likely the pericardial space, indicative of SVC rupture
(►Fig. 4). Ultrasound revealed a thin pericardial effusion,
which, given the patient’s history of radiation, was deemed
sufﬁcient to cause tamponade. Overlapping 13 mm  5 cm
Viabahn-covered stents (Gore Medical, Flagstaff, AZ) were
placed from the central aspect of the left brachiocephalic
vein to the atriocaval junction (►Fig. 5). However, the
patient rapidly decompensated, and despite aggressive
resuscitation following advanced cardiac life support
(ACLS) protocol, including pericardiocentesis, the patient
expired on the table.
Discussion
SVC Syndrome
SVCS results from elevated venous pressure in the upper
extremities and head caused by obstruction of the SVC. The
dominant cause of SVCS has varied over time, and the
majority of cases today are caused by malignancy, typically
primary bronchogenic carcinoma. Benign processes, such as
stenosis and thrombosis induced by central venous catheters,
are responsible for an increasing minority of cases.1
The majority of patients with SVCS experience face, neck,
and upper extremity swelling; dyspnea at rest; and cough.
Chest pain, dizziness, syncope, and headache occur in 10 to
20% of patients.1 While these symptoms can be alarming to
patients, death due to SVCSmay be as infrequent as 3 in 1,000
cases.2 Stridor, altered mental status, and syncope may indi-
cate possible neurologic compromise or impending respira-
tory collapse and should prompt rapid treatment.
Primary treatment of SVCS is directed at the underlying
abnormality, which for malignant conditions usually involves
chemotherapy and/or radiation therapy. Endovascular thera-
py can offer rapid and enduring symptomatic relief and is an
important adjunctive therapy. It is indicatedwhen the patient
desires rapid symptomatic relief, displays signs of respiratory
or neurologic compromise, and in cases of treatment-resis-
tant malignancy.3
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Therapeutic Stenting of the SVC
Charnsangavej and colleagues ﬁrst described endovascular
treatment of SVCS in 1986. It has since become a widely
accepted therapy because of its favorable safety and efﬁcacy
proﬁle.4 In a review of 19 studies involving 884 cases of SVC
stenting, Nguyen and colleagues found a primary efﬁcacy rate
of nearly 95%, with major complications occurring in only 4%
of cases and death in 2%. Of the 17 fatalities, 7 were caused by
severe hemorrhage, 3 by respiratory events, and 4 by cardiac
complications—including 1 cardiac tamponade.5
In this initial description of SVC stenting, Charnsangavej
and colleagues used Gianturco Z stents.4 Since then, an array
of stents have been used to treat SVCS, but there is a paucity of
data assessing individual stent performance. However, sever-
al observations may help guide stent selection. In a series of
164 patients, Fagedet and colleagues found an increased rate
of complications when stents greater than 16 mm were
used.6 Other authors have proposed that self-expanding
stents may be better suited for use in tortuous vessels and
when occlusion extends into the brachiocephalic veins.5
Finally, when thrombus extends into both brachiocephalic
veins, unilateral brachiocephalic vein stenting effectively
relieves symptoms while avoiding the higher complication
and occlusion rates associated with bilateral brachiocephalic
vein stenting.6–8
Symptomatic relief after stent placement is usually rapid.
Close to 90% of patients experience some degree of relief
within 24 hours of the procedure and another 5% within
5 days.3,9 Although stents do occlude, most patients do not
require reintervention. Gwon and colleagues found a step-
wise decrease in stent patency at 3, 6, and 12months—79, 67,
Fig. 1 Axial (a) and coronal (b) contrast-enhanced CT images of the
chest performed 4 days prior to the attempted venous reconstruction.
A spiculated right upper lobe mass (white arrow) causes near-complete
occlusion of the SVC (black arrow).
Fig. 2 Digital subtraction venogram obtained prior to intervention.
The SVC and right brachiocephalic vein are occluded and collateral
vessels (arrows) are present.
Fig. 3 Fluoroscopic image obtained during angioplasty of the bilateral
brachiocephalic veins.
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and 48%, respectively. However, patency rates with covered
stents remained greater than 90% at 1 year follow-up, which
may suggest a beneﬁt to using these devices when SVCS is
caused by inﬁltrative or aggressive tumors.9
Guidelines for intraprocedural and postprocedural anti-
coagulation are scant. Although some authors prescribe
postprocedure anticoagulation, there is a trend toward using
antiplatelet therapy with aspirin and clopidogrel alone. Fa-
gedet and colleagues found a nonsigniﬁcant trend toward
increased bleeding with heparin, warfarin, and aspirin, and
no decrease in reocclusion rates, which brings into question
the utility of these therapies.6 Three to 6 months of post-
procedure, antiplatelet therapy with aspirin and clopidogrel
is an unproven but common therapeutic regimen.
SVC Rupture and Cardiac Tamponade as a Complication
of Stenting
SVC rupture and cardiac tamponade are among the most
catastrophic complications of SVC stenting. They are fortu-
nately rare. Nguyen and colleagues found only one case of SVC
rupture among the 884 cases reviewed (0.1%).5Other authors
have reported rates of tamponade as high as 1.8%.6 A total of
16 cases of SVC perforation and hemopericardium have been
described in the literature.10–24 The majority of ruptures
became clinically apparent near the time of stenting—seven
intraprocedurally, six within 1 hour of the procedure, and one
more within 24 hours. However, fatal ruptures caused by
strut erosion into the pericardium have been reported at 3
and 6 months postprocedure.20,22 Seven of these 16 perfo-
rations resulted in death. Of the nine surviving patients, three
were successfully treated with pericardial drainage, three
with covered stent placement, and three with open surgery.
Several techniques may help mitigate the risk of SVC
rupture. Extravascular wire crossing of the stenosis can result
in caval perforation.11 To avoid this, a loop snare advanced
from a femoral access site to the inferior aspect of the
occlusion can be used as a target for the advancing wire.25
Once the stenosis is crossed, the snare can be used to create
through-and-through access to facilitate stent placement.
Vascular perforation can also occur during angioplas-
ty.14,24 There is no clear consensus on whether angioplasty
should be performed prior to stent placement, and the use of
this technique will largely depend on operator experience
and patient anatomy.When angioplasty is used, conservative
serial dilations are probably safest. If rupture is identiﬁed, the
balloon should be immediately reinﬂated to slow the rate of
extravasation.
Perforation of the SVC by stent struts can lead to intra-
pericardial hemorrhage and tamponade.16,18,20 Some authors
postulate that the risk of hemopericardium can be decreased
by placing the inferior border of the stent above the pericar-
dial reﬂection, which can be reliably predicted by the level of
the carina onﬂuoroscopy.14,26,27While the lowest 3 to 8 cmof
the SVC are contained within the pericardium, intrapericar-
dial hemorrhage from SVC perforation above this level can
still occur because themedial aspect of the SVC adheres to the
pericardium up to the level of the aortic arch.12,26 Thus,
suprapericardial stent placement likely decreases, but does
not eliminate, the probability of intrapericardial perforation.
Diagnosis of SVC Rupture and Cardiac Tamponade
Despite meticulous preprocedure planning, stenting across
irradiated and tumor-inﬁltrated vessels can lead to perfora-
tion and pericardial tamponade. Minimizing mortality from
rupture and tamponade requires prompt recognition and
treatment. In all the reported cases of intraprocedural venous
rupture, contrast extravasation and pericardial pooling were
Fig. 4 Digital subtraction venogram. Contrast material in the peri-
cardium (arrow) is indicative of SVC rupture and evolving cardiac
tamponade.
Fig. 5 Fluoroscopic image of the thorax after placement of over-
lapping 13 mm  5 cm Viabahn-covered stents (arrow). An endotra-
cheal tube is now visible.
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ﬂuoroscopically evident.11,14,17,21,23,24 However, familiarity
with the physical, electrocardiographic, and echocardio-
graphic ﬁndings of cardiac tamponade can conﬁrm angio-
graphic ﬁndings and is necessary to diagnose postprocedure
SVC rupture and cardiac tamponade.
Beck’s triad of hypotension, increased jugular venous
distension, and mufﬂed heart sounds is taught as the classic
clinical presentation of cardiac tamponade.28 However, the
triad is neither sensitive nor speciﬁc enough to be relied upon
for diagnosis.29 Patients with tamponade, including tampo-
nade due to SVC rupture, almost universally demonstrate
tachycardia and hypotension.30 Additionally, patients with
SVC rupture most commonly demonstrate dyspnea, hemop-
tysis, diaphoresis, and chest pain. These ﬁndings should
prompt ultrasound interrogation of the pericardium.
The presence of pericardial ﬂuid in the inelastic pericardi-
um causes theheart to swing back and forth and leads to atrial
and/or ventricular infolding. The “swinging heart” sign can
occasionally be observed during echocardiography and ﬂuo-
roscopy. This motion also results in alterations in the magni-
tude of the QRS complexes on electrocardiogram, that is,
electrical alternans (►Fig. 6).31 Atrial infolding can be quan-
tiﬁed by the indexof biatrial collapse—biatrial diameter at the
mid-atria divided by the diameter at the level of the mitral
and tricuspid valve during end diastole. Values of 0.85 and
below are sensitive (100%) and somewhat speciﬁc (82%) for
tamponade.32 Speciﬁcity increases to close to 100% when
infolding persists throughout systole.33
Treatment of Rupture and Tamponade
Successful management of SVC rupture and cardiac tampo-
nade requires reestablishing the integrity of the SVC and
restoring cardiac output. The extent and order of therapywill
be highly dependent on the clinical situation, particularly the
patient’s cardiovascular status. If SVC extravasation is noted
prior to cardiovascular collapse, reestablishing the integrity
of the SVC must be prioritized. When rupture is identiﬁed
after collapse, resuscitation should follow ACLS protocol,
Fig. 6 Images obtained from another patient with cardiac tamponade. (Images courtesy of Kyle Harry, MD). (a) Transthoracic echocardiogram
demonstrating a large pericardial effusion (calipers). (b) Electrocardiogram demonstrating electrical alternans, noted by alterations in the
magnitude of the QRS complexes.
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which will include the treatment of tamponade and
extravasation.
When extravasation is identiﬁed, anticoagulation should
be immediately stopped and reversed if possible. If an occlu-
sion balloon is available or rupture occurs during angioplasty,
the balloon should be inﬂated to slow the rate of extravasa-
tion. If the patient is sufﬁciently stable, covered stent place-
ment may offer deﬁnitive endovascular therapy.14,34,35 A
conservative interventionalist may consider having an ap-
propriately sized covered stent available when performing
central venous reconstructions. In all cases of rupture, car-
diothoracic surgical colleagues should be notiﬁed early in
case open repair is needed.
Restoring cardiac output through rapid pericardiocentesis
can be lifesaving. When performing central venous recon-
struction, it is prudent to have the chest prepped and an
ultrasound and pericardiocentesis tray available. The optimal
entrance site when using ultrasound guidance is the “point at
which the largest ﬂuid collection is closest to the body surface
and from which a straight needle trajectory avoids vital
structures.”36 This site is often located in the ﬁfth left inter-
costal space.36 At this site, care should be taken to avoid the
internal mammillary artery, which is found between 0.5 and
1.5 cm (mean: 0.98 cm) from the lateral sternal border.37 In
well-trained hands, emergent ultrasound-guided pericardio-
centesis is extremely safe. In a review of 92 emergent
pericardiocenteses, Tsang and colleagues reported no deaths
and only three major complications.38 This procedure can
also offer deﬁnitive therapy; 3 of the 16 reported cases of SVC
rupture with cardiac tamponade required no further therapy
after pericardiocentesis.10,11,13
If ultrasound is unavailable and the patient demonstrates
strong evidence of cardiac tamponade, a blind pericardio-
centesis utilizing a subxiphoid approach can be considered,
although it is associated with higher complication rates than
ultrasound-guided pericardiocentesis.39 With this approach,
the sheath needle is placed in the angle between the xiphi-
sternum and the left costal margin and advanced toward the
left shoulder. The needle is directed at 30 to 45 degrees
cranially until it is past the costal margin, where the angle
is decreased to 15 to 30 degrees and advanced into the
pericardium.40
In unstable patients with rapid intrapericardial hemor-
rhage, central venous reinfusion of drained pericardial blood
may be used as a temporizing measure until deﬁnitive
therapy is available.
Conclusion
Endovascular stenting of malignant SVCS is a safe and effec-
tive therapy that can help maximize a patient’s quality of life.
However, the procedure carries a small risk of major compli-
cation, including SVC perforation and cardiac tamponade.
Preprocedure planning can minimize the risk of severe com-
plications. In the event of SVC perforation and cardiac tam-
ponade, rapid diagnosis and treatment can be lifesaving.
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